Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.
Quality control for in vitro antimicrobial susceptibility testing of Pseudomonas aeruginosa versus aminoglycosides is improved by P. aeruginosa ATCC 49189, which was developed in the Clinical Microbiology Laboratory at St. Paul-Ramsey Medical Center. This strain, used by us for daily testing for the past 6 years, requires MICs that approximate therapeutic concentrations, are midrange in most dilution schemes, and are stable and reproducible.
Lally
R T
RT
Department of Pathology, St. Paul-Ramsey Medical Center, Minnesota 55101.
Woolfrey
B F
BF
Enright
M A
MA
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D011786:Quality Control
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents